Gecacitinib + ZG005 + BEVACIZUMAB for uterine cervical neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 23 Jul 2025: Trial registered, NCT07080216
  2. 23 Sep 2025: Trial started, NCT07080216

The trials

NCT07080216: Study of ZG005 in Combination With Gecacitinib in Participants With Advanced Cervical Cancer

State
Under way
Phase
Phase 1 and Phase 2
People
120 planned
Started
23 Sep 2025
Primary completion
Aug 2027
Arms
PART 1(phaseⅠ), PART 2(phase II)
Results
None posted
  1. 23 Jul 2025: Trial registered
  2. 23 Sep 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.